FMP
AMEX
16.9 USD
-5.4178 (-32.05%)
Dr. Joanne M. Hackett Ph.D.
Healthcare
Biotechnology
https://www.agexinc.com
AMEX
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation...
0001708599
US00848H1086
00848H108
1101 Marina Village Parkway
510 671 8370
US
5
Nov 29, 2018
0001708599
AMEX
Biotechnology
Healthcare
00848H108
US00848H1086
US
16.9
1.19
2.82k
18.24M
-
11.071429-35.714287
-0.46
-
-
-
-
-1.26
-
https://www.agexinc.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.